Sleep Disorders Trial, Recruiting NCT06610955 Sponsor: Ahi Evran University Education and Research Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06610955
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and between 18 and 45 years old
  • People with a body mass index (BMI) between 30 and 40, which is a measure of body weight relative to height
  • People whose excess weight is not caused by another medical condition (confirm with trial site)

Who may not be able to join:

  • People who have heart, lung, hormonal (such as thyroid or diabetes-related), or joint/immune system diseases
  • People who are currently pregnant or breastfeeding
  • People who are currently taking certain medications, including antipsychotics, some antidepressants (such as lithium, tricyclic antidepressants, or MAOIs), anti-seizure medications, antihistamines, steroid medications (glucocorticoids), or certain diabetes medications (such as sulfonylureas, insulin, or glitazones), or sex hormone medications
  • People who are currently taking the oral contraceptive pill (birth control pills)
  • People who have previously had weight-loss (bariatric) surgery
  • People who have used weight-loss medication in the last 6 months, or who are already following a structured diet and exercise program
  • People who have bone, joint, or nerve-related problems that would make it difficult to take part in aerobic exercise activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Figen Tuncay, Professor, Ahi Evran Univeristy

Phone: 5353046401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ahi Evran University Education and Research Hospital
Registry
ClinicalTrials.gov
Start date
18 October 2024
Est. completion
1 July 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Serum adipokine levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov